Grant of Options | 21-Nov-2023 | 15:06 | RNS |
Ferovinum Financing Facility | 17-Nov-2023 | 07:00 | RNS |
Director Dealing | 01-Nov-2023 | 10:59 | RNS |
Director Dealing | 25-Sep-2023 | 07:00 | RNS |
Interim Results | 18-Sep-2023 | 07:00 | RNS |
Investor Presentation via Investor Meet Company | 22-Aug-2023 | 09:00 | RNS |
Notice of Interim Results | 31-Jul-2023 | 13:56 | RNS |
Half Year Trading Update | 18-Jul-2023 | 07:00 | RNS |
Notice of Trading Update | 07-Jul-2023 | 07:00 | RNS |
Exercise of Options and Total Voting Rights | 03-Jul-2023 | 11:34 | RNS |
Exercise of Options and Total Voting Rights | 29-Jun-2023 | 11:57 | RNS |
Exercise of Options and Total Voting Rights | 27-Jun-2023 | 12:30 | RNS |
Exercise of Options and Total Voting Rights | 22-Jun-2023 | 07:00 | RNS |
Exercise of Options and Total Voting Rights | 15-Jun-2023 | 07:00 | RNS |
Exercise of Options and Total Voting Rights | 05-Jun-2023 | 15:00 | RNS |
Currency | UK Pounds |
Share Price | 39.00p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 98.50 |
52 Week Low | 38.00 |
Volume | 26,027 |
Shares Issued | 70.56m |
Market Cap | £27.52m |
RiskGrade | 1,106 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
14:04 | 10,000 @ 39.36p |
13:43 | 2,000 @ 38.10p |
11:33 | 14,027 @ 38.00p |
CEO | Andrew William Dane |
CFO | Billy McCarter |
You are here: research